482578-63-2

Basic information

• Product Name: METHYL 2-BROMOMETHYL-6-CHLORO-BENZOATE
• Synonyms: METHYL 2-BROMOMETHYL-6-CHLORO-BENZOATE Benzoic acid, 2-(bromomethyl)-6-chloro-, methyl ester;METHYL 2-BROMOMETHYL-6-CHLORO-BENZOATE;Benzoic acid, 2-(bromomethyl)-6-chloro-, methyl ester
• CAS NO: 482578-63-2
• Molecular Formula: C₉H₈BrClO₂
• Molecular Weight: 263.52
• Mol File: 482578-63-2.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 325.289 °C at 760 mmHg
• Flash Point: 150.53 °C
• Appearance: /
• Density: 1.561 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.572
• CAS DataBase Reference: METHYL 2-BROMOMETHYL-6-CHLORO-BENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-BROMOMETHYL-6-CHLORO-BENZOATE(482578-63-2)
• EPA Substance Registry System: METHYL 2-BROMOMETHYL-6-CHLORO-BENZOATE(482578-63-2)

Safety Data

• Hazardous Substances Data: 482578-63-2(Hazardous Substances Data)

Usage

General Description

Methyl 2-bromomethyl-6-chloro-benzoate is a chemical compound with the molecular formula C9H8BrClO2. It is a white to off-white crystalline solid that is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. METHYL 2-BROMOMETHYL-6-CHLORO-BENZOATE is often used as an intermediate in the synthesis of specific drugs or as a building block in the production of various organic compounds. It is important to handle this chemical with care and follow proper safety protocols, as it may be hazardous if not handled properly.

InChI:InChI=1/C9H8BrClO2/c1-13-9(12)8-6(5-10)3-2-4-7(8)11/h2-4H,5H2,1H3

Upstream product

• 21327-86-6 2-chloro-6-methylbenzoic acid 
• 99585-14-5 methyl 2-chloro-6-methylbenzoate 

Downstream Products

• 902143-88-8 methyl 2-chloro-6-(methoxymethyl)benzoate 
• 902143-86-6 2-chloro-6-dimethylaminomethyl-benzoic acid methyl ester 

Relevant articles and documents

IMPROVED METHODS, KITS, COMPOSITIONS AND DOSING REGIMENS FOR THE USE OF HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2

The present application provides improved compositions, methods, kits and dosing regimens for the use of heterocyclic compounds and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, or stereoisomers thereof. These compositions, methods, kit

Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity

A series of analogs of the immunomodulary drugs lenalidomide (1) and pomalidomide (2), in which the amino group is replaced with various isosteres, was prepared and assayed for immunomodulatory activity and activity against cancer cell lines. The 4-methyl and 4-chloro analogs 4 and 15, respectively, displayed potent inhibition of tumor necrosis factor-α (TNF-α) in LPS-stimulated hPBMC, potent stimulation of IL-2 in a human T cell co-stimulation assay, and anti-proliferative activity against the Namalwa lymphoma cell line. Both of these analogs displayed oral bioavailability in rat.

NOVEL HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS

The present invention relates to compounds of formula (I), and salts thereof, wherein P represents a 5 or 6-membered heteroaryl ring; R1 is aryl or unsaturated heterocyclyl radical optionally substituted by one or more identical or different radicals R5.